Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform

Go back to Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
(AMEX: VSQTF) Delayed: 0.30 --0 (-0%)
Previous Close $0.30    52 Week High $ 
Open $0.30    52 Week Low $ 
Day High $0.30    P/E N/A 
Day Low $0.30    EPS $ 
Volume 2,490       

(NYSE: VST) Delayed: 157.11 +6.79 (4.52%)
Previous Close $150.32    52 Week High $ 
Open $153.35    52 Week Low $ 
Day High $158.74    P/E N/A 
Day Low $151.83    EPS $ 
Volume 3,507,389